Zhan Shi
State Key Laboratory Of Coordination Chemistry
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Dual-Layer Protected Silicon Anode With In Situ Converted MnSiO3 Interlayer and Carbon Shell for Lithium-Ion Batteries.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: May 12, 2026
Novel models for predicting individualized outcomes in patients with advanced hepatocellular carcinoma receiving immunotherapy.
Journal: Frontiers in oncology
Published: November 29, 2025
Real-World Efficacy and Safety of Disitamab Vedotin (RC48-ADC) in the Treatment of HER2-Overexpressing Advanced Gastric/Gastroesophageal Junction Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: November 01, 2025
IMP metabolic mechanisms and IMPDH targeting strategies in tumor metabolic reprogramming and therapy (Review).
Journal: International journal of molecular medicine
Published: January 16, 2025
Machine Learning Model for Risk Prediction of Prolonged Intensive Care Unit in Patients Receiving Intra-aortic Balloon Pump Therapy during Coronary Artery Bypass Graft Surgery.
Journal: Journal of cardiovascular translational research
Published: September 27, 2024
Machine learning-based model development for predicting risk factors of prolonged intra-aortic balloon pump therapy in patients with coronary artery bypass grafting.
Journal: Journal of cardiothoracic surgery
Published: February 18, 2024
MiR-21-5p Promotes Osteogenic Differentiation and Calcification of Valvular Interstitial Cells by Targeting TGFBI in Calcific Aortic Valve Disease.
Journal: Iranian journal of public health
Published: February 11, 2024
A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese population.
Journal: Hepatobiliary surgery and nutrition
Published: December 07, 2023
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy.
Journal: Journal of hepatocellular carcinoma
Published: November 29, 2023
Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer.
Journal: Human vaccines & immunotherapeutics
Published: February 22, 2023
Last Updated: 09/26/2026